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Abstract
Background: Metallothioneins (MT) are small proteins, which are crucial for the distribution of heavy and transition
metals. Previously, we found in mice that knockout of MT 1 and 2 genes (MTKO) impaired spatial learning and
potentiated the learning impairment caused by developmental mercury exposure. The current study examined the
neurocognitive and neurochemical effects of MTKO with the developmental copper (Cu) supplementation.
Methods: Wildtype (WT) and MTKO mice were given supplemental Cu (0, 10 or 50 mg/l) in their drinking water
during gestation and until weaning. When the mice were young adults they were trained on the win-shift 8-arm
radial maze test of spatial learning and memory. After cognitive testing, their brains were analyzed for
norepinepherine, dopamine and serotonin levels.
Results: In the spatial learning test, wildtype mice showed the normal sex difference with males performing more
accurately than the females. This effect was eliminated by MTKO and restored by moderate Cu supplementation
during development. In neurochemical studies, MTKO caused a significant overall increase in serotonin in all of the
regions studied: the frontal cortex, posterior cortex, hippocampus, striatum, midbrain, and brainstem. MTKO also
caused a significant increase in norepinepherine in the brainstem and hippocampus. In wildtype mice, Cu
supplementation during development caused a significant decline in dopamine and norepinepherine in the
midbrain and dopamine in the frontal cortex. These effects were blocked by MTKO.
Conclusions: The normal sex difference in spatial working memory accuracy, which was eliminated by MTKO, was
restored by moderate copper supplementation. MTKO increased serotonin across all brain areas studied and
increased norepinepherine only in the hippocampus and brainstem. MTKO blocked copper-induced decreases in
dopamine and norepinepherine in the midbrain and dopamine in the frontal cortex.
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Background
Metallothionein (MT) is a cysteine-rich, low molecular
weight intracellular protein system whose function is to
uptake, transport, and regulate transition metals, such as
copper (Cu), throughout biological systems [1]. In doing
so, MT maintains an optimal amount of essential metals
and at the same time helping rid the body of non-
essential potentially toxic metals. We have previously
found in mice that knockout of MT 1 and 2 genes
(MTKO) impaired spatial learning and potentiated the
learning impairment caused by developmental mercury
exposure [2, 3]. The influence of MT manipulations on
reaction to alterations in essential metals such as Cu and
neurocognitive function has not been well characterized.
Cu is essential metal for normal neuronal physiology.
A dietary intake of 1–2 mg of Cu per day is considered
essential for humans [4]. Potential sources of Cu expos-
ure include drinking water, industry emissions, cooking
utensils, fertilizers, bactericides, fungicides, algicides,
and mineral rich foods such as vegetables, legumes, nuts,
grains, fruits, and systems, and chocolate. Cu shows a
typical developmental change with Cu concentration in
mouse brain increasing by 200 % between 10 and 20 days
after birth [5]. Changes in Cu levels have direct effects
on monoaminergic transmitter systems. Dietary Cu defi-
ciency in mice show a reduction in norepinepherine and
dopamine concentrations [6].
Abnormal levels of Cu exposure, in the form of defi-
ciency or excess, have been linked to neural dysfunc-
tions. Cu crosses the placental barrier and when
pregnant mothers are exposed to above normal Cu
levels, the fetal development of the central nervous sys-
tem is adversely affected [7]. Cu supplementation during
infancy has been associated with an increased risk of Cu
toxicity [8]. Importantly, biological reactions to Cu ex-
posure vary person to person on a genetic basis. For ex-
ample, some individuals are genetically predisposed to
abnormal Cu metabolism and thus abnormal bodily Cu
exposure. Menkes’ disease is an X-linked genetic dis-
order characterized by various mutational forms of the
ATP7A gene and is associated with Cu accumulation in
some tissues and simultaneous Cu deficiency in blood
vessels and the brain [9, 10]. Neural degeneration and
premature death are characteristic of this disorder. Wil-
son’s is an autosomal recessive genetic disorder consist-
ing of mutations to the ATP7B gene, which leads to the
release of free Cu into the bloodstream, causing toxic
damage to several organs, including the brain [10]. The
disease results in death if it goes untreated [1]. In
addition, links have been made between Cu metabolism
and several neurodegenerative disorders including Par-
kinson’s and Alzheimer’s disease [11].
Cu levels in the central nervous system are influenced
by Cu intake during perinatal development. Cu deficiency
during development can produce long-term functional
neurobehavioral impairment [12]. Dietary Cu deficiency in
mice during late gestation lowered norepinephrine con-
centrations in most brain regions. Dopamine in mice that
had Cu deficiency during late gestation was elevated in
cerebellum, medulla, hypothalamus and midbrain, but un-
changed in cerebrum and striatum. Cu repletion normal-
ized alterations in brain norepinephrine and dopamine
concentrations. These data extend previous observations
and suggest that persistent changes to brain may occur
following perinatal Cu deficiency. These data also support
the hypothesis that there is brain-regional specificity in re-
sponse to Cu deficiency and repletion [13].
MT plays a significant role in the modification of Cu
kinetics and toxicity, and is necessary for proper Cu me-
tabolism. Cu is absorbed by intestinal cells and later by
liver cells within which metallothioneins form non-toxic
complexes with Cu, leading to Cu storage [10]. Cu that
does not bind to MT is released into the blood or into
the biliary canaliculi. MT’s significant role in Cu metab-
olism is also confirmed by its apparent role in genetic
disorders of abnormal Cu metabolism. Menkes’ disease
has been associated with disrupted metallothionein
binding [9, 10]. The fact that Cu accumulation in some
tissues in Menkes’ disease is found in the form of Cu-
MT complex suggests that the disorder leads to or is as-
sociated with the dysregulation of MT gene expression
[14]. It has also been demonstrated that MT is present
in the placenta where it modulates metal transfer from
mother to fetus [15, 16].
MT’s effects in relief of oxidative stress may be related
to its role in protecting cells, tissues, and organisms
from environmental chemical exposure [17]. This ability
to alleviate oxidative effect may also serve to protect
against neural damage due to toxic insult and aging.
MT-1 and MT-2 protect the nervous system from phys-
ical injury and various compounds including interleukin
6, 6-aminonicotinamide, and kainic acid [18–20]. In
addition, research has found that MT has a role in
spatial learning and memory [3]. It has also been shown
that MT is involved in neurobehavioral development
and cognitive performance [21]. This study indicated
that MT knockout mice were more susceptible to the
neurobehavioral effects of heavy metal exposure in
utero. In a previous study, we found that knockouts of
MT 1 and 2 genes led to a developmental neurobehav-
ioral expression of mercury metal toxicity [2].
In order to study the effects of Cu on cognitive-
behavioral development and the possible modifying ef-
fects of MT in developmental neurotoxicity, two lines of
mice were tested on radial-arm maze acquisition: wild-
type and MT-1/MT-2 knockout mutants, both of which
were exposed to varying levels of Cu in utero. The trans-
genic mice that had both MT1 and MT2 genes knocked
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out were produced following a past protocol using alter-
native heavy metals [22]. These mice do not demonstrate
abnormal phenotypes except for lower levels of zinc in
serum and liver [23, 24], learning impairment [3], and
enhanced sensitivity to metal toxicity and environmental
stress [25]. We hypothesized that the condition of metal-
lothionein knock out mice exposed to Cu in utero would
be characterized by enhanced cognitive impairment. By
altering metallothionein genes, which are responsible for
Cu metabolism, this study aims to demonstrate the re-
sultant developmental neurobehavioral effects. Thus, the
study provides an additional observation of genetically
altered biological response to Cu exposure, as previously
seen in Menke’s disease and Wilson’s disease.
The current project was conducted to determine the
persisting neurobehavioral effects of MT 1 and 2 knock-
out and whether Cu supplementation during develop-
ment would reverse the impairments in cognitive
function as well as monoaminergic systems important
for cognitive function.
Methods
Mice: genotype and Cu exposure
MT-1/MT-2-knockout mice and the control wild type
mice were from the parental 129 strain provided by Jack-
son Labs. The knockout mice were homozygous for the
Mt1tm1Bri Mt2tm1Bri mutation, having been produced
by homozygous x homozygous matings. Both metallo-
thionein genes had been knocked out during a single
targeting event. The 129-derived AB-1 ES cell line was
used and the knockout mice had been back-crossed to
the 129 line for more than 22 generations.
Males and females, one pair per cage, at 8 weeks of
age were mated. Females age 8 weeks or greater were
assigned to 0, 10ug/L or 50ug/L Cu treatment. The Cu
was supplied as Cu sulfate (Sigma, St. Louis, MO, USA)
and the solutions were prepared as the base weight in
acidified water (pH 4). The females were exposed to the
Cu treatment for a minimum of 2 weeks prior to mating.
Females in the 0 μg/L condition were given acidified
water. For mating, the females were placed on water and
a male was introduced and allowed to remain in the
cage overnight. The following morning the male was re-
moved and the female returned to the appropriate Cu
treated water. Thus, the male was never exposed to Cu
and the female was without Cu treatment for a period of
approximately 16 h. The weight of the females was mon-
itored during pregnancy. The pups remained with the
mother until weaning at age 4 weeks. The pups were
then given tap water and food ad lib. Litters with 3 or
fewer animals were not used. The doses were chosen in
light of effective dosages in the literature [7]. Thus, the
study’s mice were exposed to various Cu water concen-
trations prenatally and until weaning, allowing for the
evaluation of the role Cu and MT play in developmental
neurotoxicity. With the wildtype mice there were 6, 7
and 8 litters for the Cu0, Cu10 and Cu50 conditions and
for the MTKO mice there were 7, 8 and 5 litters for the
Cu0, Cu10 and Cu50 conditions.
The parental animals were allowed to give birth and
after weaning, the offspring were housed with members
of the same sex in groups of 2–4 in a Thoren ventilated
cage rack in plastic cages with corn cob bedding at 22 ±
2 °C with a 12:12 day:night lighting cycle. All of the mice
were provided the same rodent chow and water. Once
learning was assessed in the mice and they had reached
an age of 120 days, they were euthanized. Prior to test-
ing, four of the knockout mice experienced seizures,
after which one mouse died. It is believed that vibrations
felt from a moving cart triggered these seizures.
Throughout the experiment, animals were handled with
care in accordance with an approved animal protocol
and institutional and federal animal care guidelines.
Radial-arm maze
When the offspring had reached 50 days of age, they were
tested for the effects of the metallothionein deletion
(MTKO) and the various Cu dosage treatments on spatial
learning and memory measured by radial-arm maze per-
formance. More specifically, the wild type mouse group
exposed to 0 mg/ml of CuSO4 in utero served as a control
representative of normal neurobehavioral development
and later learning and memory abilities. The wild type
groups administered 5 and 10 mg/ml of CuSO4 in utero
allowed for the observation of Cu’s effects on neurobehav-
ioral development. The MT-1/MT-2- knockout mice that
received no prenatal Cu treatment were tested for the ef-
fects of metallothionein deletion on radial-arm maze
acquisition. Lastly, the MT knockout mice prenatally ex-
posed to 5 or 10 mg/ml of CuSO4 were tested in order to
demonstrate the combined effects of metallothionein gene
deletion and Cu toxicity on the development of neurobe-
havioral function.
The maze was made from wood and painted black
with a center platform 12 cm in diameter. Eight arms
(24 × 4 cm) extended from the center and the maze was
elevated 25 cm above the floor. The radial-arm maze
was located in a room with extra-maze visual cues. Food
cups were located at the end of each arm and were bai-
ted with a small piece of sweetened cereal (Kellogg’s
Froot Loops©) was placed in order to serve as bait. Prior
to testing on the radial-arm maze, the mice were
adapted to handling (two sessions). Afterward, the mice,
while restricted to the center of the maze, were exposed
to the food reinforcements in order to insure the con-
sumption of the reinforcements (two sessions for all
mice except cohort VI which underwent 4 sessions).
Thereafter, spatial learning and memory were assessed
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using the win-shift task in which each arm was baited at
the beginning of each session. Each arm entry is
rewarded only once since the baits are not replaced. In
this way, the animal must remember where it has gone
earlier in the session in order to know where to go later.
The animals were food restricted once the behavioral
testing started.
Prior to testing in the radial-arm maze, each mouse was
placed in the center of the maze for 10 s while enclosed in
a topless and bottomless opaque cylinder 12 cm in diam-
eter and 10 cm high. The timed session began once the
cylinder had been lifted and the mouse was free to explore
the maze. When all four paws entered an arm, it was re-
corded as an arm choice. Each session lasted until the
mouse entered all eight arms or when 300 s had elapsed.
Choice accuracy was measured as the number of correct
arm entries made before an error, or Entries to Repeat. If
during a session, a mouse entered only four arms total or
less without repeating the session was not included in ana-
lysis of choice accuracy due to insufficient information on
which to base an accuracy score. Response latency was
expressed as the average time in seconds per arm entry,
which was calculated by dividing total session length by
the total number of arm entries made. If a mouse did not
enter one arm maze throughout an entire session, the re-
sponse latency was recorded as 300 s. 18 sessions were
completed for each mouse.
Neurochemical analysis
Once the mice had been euthanized, their cerebellum, brain
stem, midbrain, hippocampus, striatum, anterior cortex,
and posterior cortex were surgically isolated. The brain tis-
sue samples were placed in a 0.1 N Perchloric Acid/
100 μM EDTA solution of a 10X volume/tissue weight con-
centration. The tissue and solution combination was ho-
mogenized via an ultrasonic tissue homogenizer. In order
to remove solid cellular particulate matter, the homogenate
underwent column purification. The brain samples were di-
luted afterward 25X with purified water and norepineph-
rine, dopamine, serotonin, 3,4-Dihydroxyphenylacetic acid
(DOPAC) and 5-Hydroxyindoleacetic acid (5-HIAA) con-
centrations were determined with High-performance liquid
chromatography (HPLC) and calculated per mg of protein.
The HPLC system used consisted of an isocratic pump
(model LC1120, GBC Separations) a Rheodyne injector
(model 7725i) with a 20-μl PEEK loop, and an INTRO
amperometric detector (Antec Leyden). The electro-
chemical flow cell (model VT 03, Antec Leyden) had a
3 mm glassy carbon working electrode with a 25 μm
spacer, and an Ag/AgCl reference electrode. The cell po-
tential was set at 700 mV. The signal was filtered with a
low pass in-line noise killer, LINK (Antec Leyden) set at
a 14 s peak width and a cut off frequency of 0.086 Hz.
The signal is integrated using the EZChrom elite
chromatography software (Scientific Software Inc). The
injector, flow cell, and analytical column were placed in
the Faraday-shielded compartment of the detector where
the temperature was maintained at 30 °C.
The stationary phase was a reverse phase column
150 mm × 3.2 mm, with a 3 μm particle size and 120 Å
pore size (ESA Scientific). The mobile phase was pur-
chased from ESA Scientific and contained (50 mM
H3PO4, 50 mM citric acid, 100 mg/L 1-octanesulfonic
acid (sodium salt), 40 mg/L EDTA, 2 mM KCl and 3 %
methanol, corrected to pH 3.0 with NaOH). The mobile
phase was continually degassed with a Degasys Populaire
on-line degasser (Sanwa Tsusho Co. Ltd.) and delivered
at a flow rate of 0.50 ml/min.
Statistical analysis
Behavioral and neurochemical data were assessed by
variance analysis. The between subjects factors were
genotype, sex, and Cu treatment for the behavioral as
well as the neurochemical analyses. Repeated measures
for the behavioral data were session blocks. The
dependent measures for the win-shift radial-arm maze
task were entries to repeat (the number of correct en-
tries made before the first error) and response latency
(average time spent during each arm entry). For neuro-
chemical measurements the neurotransmitter levels per
mg of protein were the data analyzed. Neurotransmitter
turnover is a function of transmitter level divided by me-
tabolite level. The data were presented as percent of
controls for clarity. The raw data for the measures were
the basis for statistical analysis. For graphic presentation
the data were normalized to percent of control to facili-
tate comparison of treatment effects in different brain
areas and with different neurotransmitters. The thresh-
old for significance was p < 0.05. In addition, interactions
with p < 0.10 were reexamined after separation of the
interactive factors (Snedecor & Cochran, 1989). Any sig-
nificant interactions found were followed up by analyses
of the simple main effects of each factor at each of the
repeated measures (Keppel, 1973). The threshold for sig-
nificance for these simple main effects was p < 0.05. The
50ug/L Cu exposure in the drinking water caused signifi-
cant (p < 0.001) hypodipsia compared with controls with
an average 27.5 % reduction in water consumption.
Therefore, the data from this group was removed from
the statistical analyses since the effects of this level of
high copper could not be differentiated from the effects
of hypodipsia. The lower 10ug/L Cu exposure did not
cause significant hypodipsia relative to controls.
Results
Water consumption and clinical effects
Because the copper was added to the drinking water it
was important to measure the consumption to determine
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the dose administered and whether the copper in the
water affected the amount of water consumed. There was
a significant main effect of copper treatment on water
consumption (F(2,62) = 24.45, p < 0.005) The Cu0 dams
consumed a mean of 3.9 ± 0.2 ml of water per day, the
Cu10 dams averaged 3.7 ± 0.2 ml of water per day and the
Cu50 dams averaged 2.9 ± 0.2 ml of water per day. Be-
cause of the significant (p < 0.001) hypodipsia, 26 % de-
creased from control rates, caused by the Cu50 condition,
this treatment group was eliminated from the statistical
analyses because direct effects of this concentration of
copper on development would be confounded with the ef-
fects secondary to hypodipsia of the dams.
Radial-arm maze learning
Radial-arm maze choice accuracy and response latency
showed significant effects (Fig. 1a-b). The genotype main
effect was significant (F(1112) = 4.29, p < 0.05) with the
MTKO mice performing significantly less accurately than
wildtype mice (WT= 5.30 ± 0.09 and MTKO= 4.95 ± 0.11).
a
b
Fig. 1 a-b Radial-arm maze choice accuracy, entries to repeat (mean ± sem). The Genotype x Session Block (p < 0.05) prompted simple main effects
tests which showed that the MTKO mice had significantly (p < 0.0005) worse performance during sessions 1–6. The Genotype x Cu interaction (p <
0.08). prompted simple main effects tests which showed that Cu50 significantly (p < 0.05) impaired choice accuracy during sessions 13–18 in WT but
not MTKO mice. During sessions 1–6 the MTKO mice in the Cu0 and Cu50 treatment groups were significantly worse than the wildtype mice in the
same treatment groups. Tobacco extract and nicotine effects on response latencRadial-arm maze response latency Number of rats/condition: Wildtype
Cu0 males = 16, Wildtype Cu0 females = 13; Wildtype Cu10 males = 23; Wildtype Cu10 females = 13; MTKO Cu0 males = 11; MTKO Cu0 females = 19;
MTKO Cu10 males = 10; MTKO Cu10 females = 15
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The effect of sex was significant (F(1112) = 15.38, p <
0.0005). Males averaged 5.42 ± 0.09 and the MTKO mice
averaged 4.95 ± 0.10). The session block main effect was
significant (F(2224) = 45.58, p < 0.0005). The significant Cu
x sex interaction (F(1112) = 5.18, p < 0.025) prompted sim-
ple main effects tests of copper in each sex. Females
showed a significant choice accuracy impairment caused by
Cu10 (p < 0.05), whereas no effect was seen in males. The
significant genotype x sex x Cu interaction (F(1112,) = 7.00,
p < 0.01) prompted simple main effects tests which showed
that only the MTKO females showed a significant effect of
Cu0 vs.Cu10 (p < 0.005) with copper significantly reducing
entries to repeat in the MTKO female mice (4.47 ± 0.19)
relative to MTKO female not given supplemental copper
(5.16 ± 0.17). There was a significant main effect of the re-
peated measure of six session block (F(2224) = 65.22, p <
0.0005) reflecting the improvement in choice accuracy with
training, rising from 4.42 ± 0.08 entries to repeat during
sessions 1–6 to 5.29 ± 0.09 during trials 7–12 and 5.71 ±
0.11 during sessions 13–18. The significant ((F(2224) =
3.50, p < 0.01) session block x sex x copper interaction was
followed up by tests of the simple main effects of sex and
copper treatment at each of block of sessions. During the
initial six training sessions there were no significant effects
of sex or copper treatment. During the middle six sessions
(7–12) there were significant copper effects in both the
males (p < 0.05) and females (p < 0.005) with copper caus-
ing higher entries to repeat in males (Cu0 = 5.44 ± 0.19,
Cu10 = 5.81 ± 0.16) and lower entries to repeat in females
(Cu0 = 5.30 ± 0.16, Cu10 = 4.53 ± 0.16). By the last six-
session block (13–16) there were no significant effects of
Cu treatment in either males or females.
Response latency in the radial-arm maze showed that
there were significant main effects of genotype (F(1112) =
27.99, p < 0.0005) and sex (F(1112) = 13.66, p < 0.0005). The
MTKO mice had significantly longer latencies (41.0 ± 2.3 s/
arm entry) than wildtype controls (25.6 ± 1.4 s/arm entry).
The sex difference consisted of males (26.7 ± 1.7 s/arm
entry) being faster than females (38.6 ± 2.2 s/arm entry).
There was no significant main effect of Copper treatment
with the latency measure. The interactions of genotype x
copper (F(1112) = 3.85, p = 0.052) and sex x copper
(F(1112) = 4.31, p < 0.05) were followed up by tests of the
simple main effects. With regard to copper effects on
latency in either of the genotypes, neither the WT nor the
KO groups individually showed significant effects of Cu10
on response latency. When broken down by sex there were
significant elevations in response latency in both males (p <
0.0005) and females (p < 0.005) but the addition of copper
eliminated these effects (Fig. 2). Session Block (F(2224) =
17.91, p < 0.0005). There was also a significant (F(2224) =
19.32, p < 0.0005) interaction of genotype x session block.
Tests of the simple main effects of genotype at each session
block showed that there was a significantly (p < 0.0005)
elevated latency in the MTKO group (58.9 ± 6.0) relative to
wildtype mice (25.8 ± 1.6) in the first six sessions and dur-
ing the final six session (wildtype = 25.1 ± 1.6, MTKO=
33.4 ± 1.8, p < 0.025), but not in the middle or training. Fi-
nally, there was a significant interaction of copper x sex x
session block (F(2224) = 4.10, p < 0.025), but copper treat-
ment was not found to have significant effects on response




Dopamine With frontal cortical dopamine (DA) concen-
trations (Fig. 2a) there was a significant (F(1113) = 6.01, p <
0.05) main effect of genotype with the MTKO mice (276.2
± 9.6) having significantly lower DA in the frontal cortex
than wildtype controls (309.3 ± 8.1). The main effect of sex
was also significant (F(1113) = 4.03, p < 0.05) with males
(307.9 ± 9.0) having higher DA levels than females (279.4 ±
8.7). DA turnover in the frontal cortex (Fig. 2d) showed a
significant (F(1113) = 8.90, p < 0.005) main effect of geno-
type with the MTKO mice (0.169 ± 0.006) having higher
DA turnover than wildtype (0.145 ± 0.004). There was also
a significant main effect of sex, (F(1113) = 7.55, p < 0.01)
with females (0.168 ± 0.005) having a higher DA turnover
rate than males (0.146 ± 0.005). There was an interaction of
Cu x sex (F(2113) = 3.11, p < 0.09), which was followed up
by tests of the simple main effects. However the simple
main effects of copper in either sex was not significant
(Fig. 2b).
Serotonin In the frontal cortex the MTKO mice (139.7
± 2.4) showed a significant (F(1113) = 13.62, p < 0.0005)
elevation in 5HT levels compared with wildtype controls
(126.9 ± 2.1) (Fig. 2b). 5HT turnover in the frontal cortex
(Fig. 2e) showed a significant (F(1109) = 13.77, p <
0.0005) main effect of genotype with a decrease in 5HT
turnover in the MTKO mice (1.27 ± 0.05) vs. wildtype
mice (1.55 ± 0.04) relative to wildtype controls.
Norepinepherine No significant effect of Cu treatment,
genotype or sex was seen with NE in the frontal cortex
(Fig. 2c).
Posterior cortex
Dopamine No significant Cu, genotype and sex main ef-
fects on DA levels (Fig. 3a) were seen in the posterior
cortex (Fig. 3). DA turnover in the posterior cortex
could not be assessed due to problems with analysis of
DOPAC for this region.
Serotonin In the posterior cortex the MTKO mice (55.9 ±
2.3) also showed a significant (F(1111) = 26.20, p < 0.0005)
increase in 5HT levels (Fig. 3b) compared with wildtype
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controls (41.8 ± 1.2) (Fig. 3). There were no other signifi-
cant main effects or interactions. 5HT turnover in the pos-
terior cortex (Fig. 3d) as in the frontal cortex there was a
significant main effect of sex (F(1110) = 4.11, p < 0.05). The
females (0.61 ± 0.01) had significantly greater turnover than
males (0.58 ± 0.01).
Norepinepherine In the posterior cortex there were no
significant main effect on NE levels (Fig. 3c). There was
an interaction of genotype x sex x copper (F(2105) =
3.20, p < 0.08), which was followed up by tests of the
simple main effects of copper in each genotype for each
sex. However, none of the simple main effects was
significant.
Hippocampus
Dopamine There was no significant main effect of geno-
type (Fig. 4a). The main effect of sex was significant
(F(1113) = 4.28, p < 0.05) with females (17.7 ± 1.6) having




Fig. 2 a-cFrontal cortical DA, 5HT and NE levels (mean ± sem) for each sex, percent of WT Cu0 control mean. There were significant main effect
of MTKO increasing frontal cortical DA (p < 0.05) 5HT (p < 0.005) levels relative to WT mice. With DA levels there was also a significant sex effect
with males having higher levels than females (p < 0.05). Number of rats/condition: Wildtype Cu0 males = 16, Wildtype Cu0 females = 13; Wildtype
Cu10 males = 23; Wildtype Cu10 females = 13; MTKO Cu0 males = 11; MTKO Cu0 females = 19; MTKO Cu10 males = 10; MTKO Cu10 females = 15.
d-e Frontal cortical DA and 5HT turnover (mean ± sem) for each sex, percent of WT Cu0 control mean. MTKO caused a significant (p < 0.05)
increase in DA turnover relative to WT mice. In contrast the MTKO mice had significantly (p < 0.0005) lower 5HT turnover than wildtype controls.
Males had significantly (p < 0.01) lower DA turnover in the frontal cortex than females
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The genotype x sex (F(1113) = 5.10, p < 0.05) and sex x
Cu (F(2113) = 10.06, p < 0.005) interactions were
followed up by tests of the simple main effects. They
showed significant MTKO-induced increase in females
(p < 0.01) increasing DA levels (wildtype = 14.4 ± 1.9,
MTKO = 20.3 ± 2.4), but not in males. There was a sig-
nificant effect of Cu10 μg/l (21.7 ± 2.8) increasing levels
in females relative to female controls (13.8 ± 1.2). No ef-
fect was seen in males. With DA turnover (Fig. 4d) the
main effect showed that Cu significantly (F(2,74) = 5.65,
p < 0.05) decreased DA turnover with the controls aver-
aging 0.80 ± 0.04 and the Cu10 group 0.66 ± 0.03
(Fig. 4b). Significant interactions were seen with sex x
Cu (F(1,74) = 9.24, p < 0.005) and genotype x sex
(F(1,74) = 6.25, p < 0.05). The simple main effects tests
showed that females had a significant (p < 0.0005) re-
duction in DA turnover (0.57 ± 0.03) relative to ve-
hicle control (0.84 ± 0.05, whereas there was no
significant effect in males. The tests of simple main
effects of genotype for each sex did not detect any
significant effects.
Serotonin There was a significant (F(1112) = 7.86, p <
0.005) main effect of genotype on 5HT levels (Fig. 4b),
with MTKO mice (299.4 ± 4.5) having elevated
hippocampal 5HT levels compared with wildtype mice
(277.3 ± 5.3). The main effect of sex was significant
(F(1112) = 6.03, p < 0.05) with females (297.9 ± 5.8) hav-
ing higher hippocampal 5HT levels than males (277.3 ±
4.3). With 5HT turnover (Fig. 4e) the main effect of
genotype was significant (F(1112) = 7.31, p < 0.01) with
MTKO mice (0.659 ± 0.012) having higher hippocampal
5HT turnover than wildtype (0.602 ± 0.012). The Cu
main effect showed a significant decrease (F(1112) =
6.13, p < 0.05) with the controls averaging 0.653 ±
0.011 and the Cu10 group 0.605 ± 0.013. The signifi-
cant genotype x Cu interaction (F(1112) = 7.19, p <
0.01) was followed up by tests of the simple main ef-
fects. These showed with the wildtype mice showed a
significant (p < 0.0005) effect of copper decreasing
serotonin turnover (Cu0 = 0.650 ± 0.017, Cu10 = 0.565
± 0.015) whereas there was no significant effect of
copper in the MTKO mice (Fig. 4b).
Norepinepherine There was a significant (F(1113) =
20.57, p < 0.0005) main effect of genotype (Fig. 4c), with
the MTKO mice (191.5 ± 2.8) having higher hippocam-
pal NE levels than the wildtype mice (173.2 ± 3.5). There
was a significant main effect of sex (F(1113) = 6.87, p <
a b
c d
Fig. 3 a-c Posterior cortical DA, 5HT and NE (mean ± sem) for each sex, percent of WT Cu0 control mean. In the posterior cortex there was a
significant (p < 0.0005) main effect of MTKO increasing 5HT levels relative to WT mice. Number of rats/condition: Wildtype Cu0 males = 16,
Wildtype Cu0 females = 13; Wildtype Cu10 males = 23; Wildtype Cu10 females = 13; MTKO Cu0 males = 11; MTKO Cu0 females = 19; MTKO Cu10
males = 10; MTKO Cu10 females = 15. d 5HT turnover was significantly (p < 0.05) higher in females than males
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0.05) with males (186.1 ± 3.2) having higher hippocampal
NE levels than females (177.0 ± 3.6).
Striatum
Dopamine There was not a significant (F(1112) = 10.69,
p < 0.005) main effect of genotype (Fig. 5a). With DA
turnover there was a significant main effect of Cu treat-
ment (F(1112) = 6.19, p < 0.05) with lowering of striatal
DA turnover (Fig. 5d) by Cu10 (0.102 ± 0.003) relative to
untreated controls (0.118 ± 0.006).
Serotonin There was a very significant (F(1112) =
10.69, p < 0.005) elevation of striatal serotonin (Fig. 5b)
in the MTKO mice (79.83 ± 1.15) relative to wildtype
controls (70.44 ± 2.35) (Fig. 5a). There were no other
significant main effects or interactions. With 5HT





Fig. 4 a-c Hippocampal DA, 5HT and NE (mean ± sem) for each sex, percent of WT Cu0 control mean. There was a significant (p < 0.05) main effect of
sex on DA levels with females greater than males. With genotype comparisons female MTKO mice had increased DA relative to WT in females. NE
(p < 0.0001) and 5HT (p < 0.005) levels. Number of rats/condition: Wildtype Cu0 males = 16, Wildtype Cu0 females = 13; Wildtype Cu10 males = 23;
Wildtype Cu10 females = 13; MTKO Cu0 males = 11; MTKO Cu0 females = 19; MTKO Cu10 males = 10; MTKO Cu10 females = 15. d-e Hippocampal DA
turnover (mean ± sem) for each sex, percent of WT Cu0 control mean. DA turnover was significantly decreased by Cu10 (p < 0.025) in females.
Hippocampal 5HT turnover was decreased by copper in the WT (p < 0.0005) but not MTKO mice. The MTKO mice had significantly (p < 0.01) greater
5HT turnover than wildtype
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(F(1112) = 10.02, p < 0.005) with females (0.434 ±
0.006) having higher turnover rates than males (0.410
± 0.005) (Fig. 5e). There was an interaction of geno-
type x sex (F(2112) = 3.20, p < 0.08) that prompted
analyses of the simple main effects. MTKO males
(0.424 ± 0.008) showed a significantly (p < 0.05) in-
creased striatal serotonin turnover relative to wildtype
males (0.394 ± 0.006). In contrast, no effects were
seen in females.
Norepinepherine There were no significant effects
detected concerning NE levels in the striatum (Fig. 5c).
Midbrain
Dopamine There were no significant effects on DA in
the midbrain (Fig. 6a). With DA turnover there was a
significant genotype main effect (F(1108) = 12.67, p <




Fig. 5 a-c Striatal NE, DA and 5HT (mean ± sem) for each sex, percent of WT Cu0 control mean.. The MTKO males had significantly(p < 0.005)
higher 5HT level than WT males. Number of rats/condition: Wildtype Cu0 males = 16, Wildtype Cu0 females = 13; Wildtype Cu10 males = 23;
Wildtype Cu10 females = 13; MTKO Cu0 males = 11; MTKO Cu0 females = 19; MTKO Cu10 males = 10; MTKO Cu10 females = 15. d-e Striatal DA and
5HT turnover (mean ± sem) for each sex, percent of WT Cu0 control mean. There was a significant (p < 0.05) decrease in DA turnover caused
by Cu10
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midbrain (0.48 ± 0.01) than the wildtype controls (0.44 ±
0.01) (Fig. 6d).
Serotonin There was a highly significant (F(1109) =
23.15, p < 0.0005) main effect of genotype on midbrain
serotonin levels with wildtype controls averaging 408.3
± 9.0 and the MTKO mice averaging 476.1 ± 10.0
(Fig. 6b). The genotype x sex interaction (F(1109) = 3.57,
p < 0.07) prompted tests of the simple main effects of
genotype in each sex. Both male (p < 0.0005) and female
(p < 0.05) MTKO mice showed significant elevations is
serotonin relative to wildtype controls. With 5HT turn-
over (Fig. 6e) there were significant main effects of geno-
type (F(1109) = 4.52, p < 0.05) with the MTKO mice
(0.536 ± 0.008) having lower turnover than the wildtype
mice (0.552 ± 0.009) (Fig. 6e). There was a significant
main effect of sex (F(1109) = 17.26, p < 0.0005) with
males having lower turnover (0.525 ± 0.008) than fe-
males (0.566 ± 0.009). There were significant two-way
interactions of genotype x Cu (F(2109) = 4.46, p <
0.05) and sex x copper (F1109) = 3.98, p < 0.05). There














0 10 0 10
Females
Developmental Copper Effects on Midbrain Dopamine Turnover















0 10 0 10
Females
Developmental Copper Effects on Midbrain Serotonin Turnover




Fig. 6 a-c Midbrain DA (mean ± sem) for each sex, percent of WT Cu0 control mean. With 5HT there was a significant (p < 0.0005) main effect of
genotype with higher levels in the MTKO vs. WT mice. Number of rats/condition: Wildtype Cu0 males = 16, Wildtype Cu0 females = 13; Wildtype
Cu10 males = 23; Wildtype Cu10 females = 13; MTKO Cu0 males = 11; MTKO Cu0 females = 19; MTKO Cu10 males = 10; MTKO Cu10 females = 15.
d-e Midbrain DA and 5HT turnover (mean ± sem) for each sex, percent of WT Cu0 control mean. DA turnover was significantly (p < 0.001)
increased in MTKO vs. WT mice. With 5HT turnover, there was a significant (p < 0.05) decrease with copper treatment in WT males, but a
significant(p < 0.05) increase in MTKO females
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copper (F(1,109) = 3.29, p < 0.08) prompting simple
main effects. So the simple main effects tests were
made at this level. The wildtype males showed a sig-
nificant decrease (p < 0.05) with copper treatment and
MTKO females showed a significant (p < 0.05) in-
crease with copper treatment.
Norepinepherine There were no significant effects on
NE levels in the midbrain (Fig. 6c).
Brainstem
Dopamine There was a significant main effect of geno-
type (F(1110) = 4.45, p < 0.05) with the MTKO mice
(31.2 ± 1.9) having higher dopamine levels in the brain-
stem than wildtype controls (26.7 ± 1.1) (Fig. 7a). With
DA turnover there was a significant (F(1,90) = 5.65, p <
0.05) effect of genotype with regard to dopamine turn-
over in the brainstem (Fig. 7d). The MTKO mice aver-
aged 0.72 ± 0.04 while the wildtype controls averaged
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Fig. 7 a-c Brainstem DA, 5HT and NE (mean ± sem) for each sex, percent of WT Cu0 control mean. There was a significant main effect of genotype
with DA levels (p < 0.05) with MTKO causing an overall increase. A robust effect was seen with significantly (p < 0.0005) higher 5HT levels in male
MTKO mice relative to male WT. NE levels in MTKO mice were significantly (p < 0.005) higher than WT regardless of sex. Number of rats/condition:
Wildtype Cu0 males = 16, Wildtype Cu0 females = 13; Wildtype Cu10 males = 23; Wildtype Cu10 females = 13; MTKO Cu0 males = 11; MTKO Cu0
females = 19; MTKO Cu10 males = 10; MTKO Cu10 females = 15. d-e Brainstem DA and 5HT turnover (mean ± sem) for each sex, percent of WT Cu0
control mean. With DA turnover there was a significant (p < 0.05) main effect of genotype with MTKO mice having higher turnover than WT mice.
With 5HT turnover there was a significant (p < 0.05) decrease caused by Cu10 in female WT mice, but a significant (p < 0.005) increase in female MTKO
mice. There was a significant (p < 0.001) sex effect with males having lower turnover than females
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sex x copper (F(1,90) = 2.81, p = 0.097), however none of
the simple main effects of copper treatment in either
genotype of either sex were significant.
Serotonin As in the other brain regions there was a very
significant (F(1112) = 22.94, p < 0.0005) effect of geno-
type on serotonin levels in the brainstem with MTKO
mice (386.2 ± 10.3) having higher levels than wildtype
mice (313.4 ± 10.6) (Fig. 7b). There was a genotype x sex
interaction (F(1112) = 4.32, p < 0.05) that prompted tests
of the simple main effects. Males (p < 0.0005) but not fe-
males (p = 0.059) showed significantly elevated brainstem
serotonin levels. With 5HT turnover (Fig. 7e) there was
a significant (F1112) = 11.66, p < 0.001) main effect of
sex with the males (0.64 ± 0.01) showing a lower turn-
over than females (0.70 ± 0.02). There were also signifi-
cant interactions of genotype x Cu (F(1,112) = 5.63, p <
0.05) and genotype x Cu x sex (F(2112) = 7.28, p < 0.01).
With the wildtype mice the Cu10 dose caused a signifi-
cant (p < 0.05) decrease in serotonin turnover, but this
was not seen in the MTKO mice (Fig. 7e). The simple
main effects within each sex showed no significant effect
with males. However with females the wildtype mice
showed a significant decrease in serotonin turnover with
the Cu10 (p < 0.05), while the MTKO female mice
showed that Cu10 dose caused a significant (p < 0.005)
increase in serotonin turnover relative to MTKO female
mice not given supplemental Cu. No significant effects
were seen in males.
Norepinepherine There was a significant (F(1112) =
10.95, p < 0.005) genotype effect with the MTKO (409.4
± 7.2) mice having higher brainstem NE levels than wild-
type mice (378.6 ± 5.8) (Fig. 7c).
Correlation of memory and neurochemical measures
The relationship between choice accuracy on the radial-
arm maze (mean entries to repeat sessions 1–18) and sero-
tonin, dopamine and norepinepherine measures were de-
termined. Serotonin measurements in several brain regions
showed significant correlations with memory performance.
There was a significant negative correlation of hippocam-
pal (p < 0.001, r2 = 0.099) serotonin levels with radial-arm
maze choice accuracy, with lower concentrations associ-
ated with better choice accuracy. In the striatum, serotonin
turnover had a significant (p < 0.0005, r2 = 0.112) negative
correlation with radial-arm maze choice accuracy with
lower turnover rates associated with better choice accur-
acy. Similar significant correlations were seen with sero-
tonin turnover in the midbrain (p < 0.05, r2 = 0.039) and
the brainstem (p < 0.05, r2 = 0.043). Dopamine levels in the
frontal cortex had a positive correlation with better choice
accuracy (p < 0.05, r2 = 0.041). Dopamine turnover in the
frontal cortex had a negative correlation with radial-arm
maze choice accuracy (p < 0.01, r2 = 0.064).
Discussion
Copper added to the drinking water produced significant
neurochemical effects in the offspring in all subcortical
areas (Table 1). Effects were seen with DA and 5HT but
not NE. Additional copper increased DA turnover in the
posterior cortex in females. In contrast, additional cop-
per decreased DA turnover and increased DA levels in
the hippocampus in females. In the striatum additional
copper decreased DA turnover regardless of sex. 5HT
turnover was significantly decreased by copper in the
hippocampus and brainstem of WT but not MTKO
mice. In the midbrain, copper had opposite effects on
5HT turnover in males (decrease) and females (in-
crease). In the brainstem copper treatment had opposite
effects in female WT (decreased) and female MTKO (in-
creased) mice.
The more prominent neurochemical effects of add-
itional copper in females may be related to the selective
effects of additional copper impairing radial-arm maze
accuracy in females. In particular the sex-selective effects
of additional copper on DA in the hippocampus of fe-
male rats may be relevant to the impairment since hip-
pocampal DA innervation has been shown to be
important for spatial memory function [26]. Also rele-
vant to the sex-selective copper induced radial-arm
maze impacts may be copper effects on serotonin in
more caudal parts of the brain. In the midbrain there
were opposite effects of copper addition on 5HT turn-
over with increased turnover in males and decreased
turnover in females which matches the improved radial-
arm maze accuracy in males and impaired performance
in females given added copper. Even more to the point
was the finding of opposite significant effects of added
copper decreasing 5HT turnover in female WT mice
and significantly increased 5HT turnover in female
MTKO mice. This matched the selective radial-arm
maze accuracy impairment of MTKO female mice by
supplemental copper.
Knockouts of genes for metallothionein 1 and 2
(MTKO) produced significant impairments of radial-arm
maze choice accuracy [2, 3]. The effect was seen princi-
pally in males. In rodents as well as other mammals,
males are often seen to perform more accurately than fe-
males on spatial tasks like the radial-arm maze [27, 28].
The normal male-female difference with males having
higher accuracy than females in the spatial radial-arm
maze was also seen in wildtype mice in the current
study. Male MTKO mice had a choice accuracy impair-
ment, which brought them down to WT female levels.
Moderate copper supplementation during development
caused significant effects on radial-arm maze choice
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accuracy. Cu10 reversed the memory impairment caused
by MTKO. In contrast, this same level of copper supple-
mentation caused impaired memory performance in
MTKO females. The net effect of the moderate Cu sup-
plementation was to re-establish the sex difference in
spatial memory absent in MTKO mice without Cu
supplementation.
There were also a variety of persistent neurochemical
effects in monoaminergic neurotransmitter systems. Pre-
viously, we found that serotonin levels were substantially
higher in the frontal cortex of MTKO mice than wild-
type (WT) controls [2]. The current study replicated this
finding of increased serotonin levels in the in the frontal
cortex of MTKO mice. It also considerably extended the
Table 1 Summary of copper, genotype and sex effects on dopamine, serotonin and norepinephrine
Copper MTKO Sex
Frontal Cortex
DA Level −11 % MTKO <WT +10 % Males > Females
DA Turnover +17 % MTKO >WT −13 % Males < Females
5HT Level +10 % MTKO >WT




5HT Level +34 % MTKO >WT
5HT Turnover −6 % Males < Females
NE Level
Hippocampus
DA Level +56 % Cu > Con Females +41 % MTKO >WT Females
DA Turnover −31 % Cu < Con Females
5HT Level +8 % MTKO >WT −7 % Males < Females
5HT Turnover −13 % Cu < Con in WT
NE Level +11 % MTKO >WT +5 % Males > Females
Striatum
DA Level
DA Turnover −14 % Cu < Con





DA Turnover +10%MTKO >WT
5HT Level +17 % MTKO >WT
5HT Turnover −7 % Cu < Con WT Males
+10 % Cu > Con MTKO Females
NE Level
Brainstem
DA Level +17 % MTKO >WT
DA Turnover +13 % MTKO >WT
5HT Level +35 % MTKO >WT Males
5HT Turnover −12 % Cu < Con female WT
+17 % Cu > Con Female MTKO
NE Level +8 % MTKO >WT
Petro et al. BMC Pharmacology and Toxicology  (2016) 17:55 Page 14 of 16
finding to demonstrate in a novel finding significantly
higher serotonin levels of the posterior cortex, hippo-
campus, striatum, midbrain and brainstem of MTKO
mice. In addition, serotonin turnover was significantly
lowered by MTKO in the frontal cortex. Dopamine and
norepinepherine were altered by MTKO as well, but in
much more modest ways. Dopamine turnover was in-
creased by MTKO relative to WT in the frontal cortex,
midbrain and brainstem. Norepinepherine was increased
by MTKO relative to WT just in the hippocampus and
brainstem.
Cu supplementation had effects on behavioral function
and neurochemical indices. Several effects were seen, re-
gardless of genotype of the mice. Cu10 caused a de-
crease in hippocampal and striatal dopamine turnover.
In the hippocampus this was restricted to females, as
was the substantial copper induced increase in dopamine
levels. MTKO modified reaction to Cu supplementation
in many of the neurochemical indices. In WT mice
Cu10 caused a significant decrease in hippocampal sero-
tonin turnover. In the brainstem the Cu10 supplementa-
tion significantly decreased serotonin turnover in
wildtype, but not MTKO mice. In wildtype mice, Cu
supplementation during development caused a signifi-
cant decline in dopamine and norepinepherine in the
midbrain and dopamine in the frontal cortex. These ef-
fects were blocked by MTKO.
There were sex effects on DA markers and differential
effects of Cu on DA in males and females. Overall, males
had higher DA concentrations in the frontal cortex,
whereas females had higher DA concentrations in the
hippocampus. In the hippocampus, the higher DA levels
in females were driven by the MTKO females, which
were higher than wildtype females, which did not differ
from males or either genotype. Also in the hippocampus,
Cu10 increased DA levels in females, but not males. In
the striatum, MTKO females but not males showed
higher DA levels. In the posterior cortex, there was a sex
interaction with genotype in which in which female
MTKO mice had higher DA turnover than wildtype fe-
males whereas no effect was seen in males. In addition,
there was an interaction of sex with Cu in which females
showed an increase in DA turnover in the posterior cor-
tex after Cu10 treatment, but no effects were seen with
the higher dose or with either dose in males. The lower
dose of Cu (Cu10) but not the higher dose also de-
creased hippocampal DA turnover.
Decreased serotonin levels in all regions in MTKO mice
were the most pervasive effect of the entire study. As seen
previously [2]. In the striatum this elevation in serotonin
in MTKO mice was limited to females, but in the other
areas it was seen in both sexes. Serotonin turnover was
decreased in the frontal and posterior cortices and mid-
brain of MTKO mice compared with wildtype mice.
Females had higher serotonin concentrations than
males in the posterior cortex . They had higher sero-
tonin turnover than males in the hippocampus. Females
had larger effects of MTKO than males with regard to
serotonergic systems. The MTKO increased serotonin
levels in the all areas tested, particularly in the posterior
cortex and brainstem. Cu treatment also affected sero-
tonin systems but in a complex fashion. Cu significantly
decreased hippocampal serotonin turnover but MTKO
mice were not significantly affected. In the midbrain
wildtype males showed a significant decrease in sero-
tonin turnover caused by Cu. In contrast, MTKO fe-
males showed increased serotonin turnover with Cu10
treatment. In the brainstem the wildtype mice the Cu10
caused a decrease in serotonin turnover. The simple
main effects within each sex showed no significant effect
with males. However with females the wildtype mice
showed a decrease in serotonin turnover with the Cu10
while the MTKO female mice showed that Cu10 caused
an increase in serotonin turnover relative to MTKO fe-
male mice not given supplemental Cu.
Norepinepherine was elevated in the hippocampus and
brainstem of MTKO mice, though quite modestly. Males
in general had higher hippocampal norepinepherine than
females. Though this was also a fairly modest effect.
There were significant relationships between regional
transmitter levels and memory performance though these
were modest. There were inverse correlations between
average choice accuracy during radial-arm maze and sero-
tonin systems in several brain areas. The hippocampal and
brainstem levels of serotonin showed this inverse correl-
ation with radial-arm maze choice accuracy. Similar in-
verse correlations were seen with striatal serotonin
turnover rates and radial-arm maze choice accuracy.
Other studies have found that serotonergic systems in the
hippocampus are important for memory. With dopamine
systems, only one region showed a significant correlation
with radial-arm maze choice accuracy. Dopamine turn-
over in the frontal cortex had a negative correlation with
choice accuracy. Frontal cortical dopamine has been
found to be important for memory function [29].
Conclusions
This study showed that MTKO mice were more susceptible
to the neurobehavioral effects of developmental Cu expos-
ure. This effect may be a result of greater retention of Cu
and the lack of metallothioneins 1 and 2 to shepherd Cu to
organs, including the brain. Future studies should look at
the role other steps in Cu metabolism, such as ceruloplas-
min have in neurocognitive development [10].
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